MEN 2019: 16th International Workshop on Multiple Endocrine Neoplasia

MEN 2019: 16th International Workshop on Multiple Endocrine Neoplasia is organized by The University of Texas MD Anderson Cancer Center and will be held from Mar 26 - 29, 2019 at The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

Target Audience:
This conference should be of value to clinicians (including physicians, nurse practitioners, physician assistants and genetic counselors), researchers and trainees (students, residents, and fellows).

Accreditation/Credit Designation:
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 16.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Description:
In keeping with the spirit of the original MEN workshop, MEN2019 will focus on emerging topics in the genesis and therapy of malignant endocrine tumors associated with multiple endocrine neoplasia. The goal of the workshop will be to provide an outline for basic and clinical research focused on these malignant manifestations.  The meeting will bring together local and international experts on multiple endocrine neoplasia to focus on
these subjects.

A significiant portion of the meeting will be spent in workshops centered on emerging topics and the development of an international roadmap for future research and clinical trials.

The remainder of the meeting will be composed of large group didactic sessions.  The University of Texas MD Anderson Cancer Center is a leader in the development of new therapies for cancer.  Our goal is to combine the extensive local scientific and clinical talent at MD Anderson along with international experts to allow focus on emerging topics including new directions in immunotherapy, emerging concepts in the use of signaling pathway inhibitors, genetic diagnosis & therapy and new clinical advances that impact management of endocrine tumor syndromes.

A specific outcome of this conference will be a white paper summarizing the goals of this work.

Educational Objectives:
After attending the conference, participants should be able to: 
• Identify and utilize alternative therapies to the traditional targeted therapy for the treatment of medullary thyroid cancer that may benefit their patients (Knowledge, Competence, Performance);
• Gain an awareness of modern therapy for pancreatic neuroendocrine tumors so that the most efficacious therapy may be delivered (Knowledge, Competence, Performance, Patient Outcomes); 
• Utilize options to treat symptoms ofexcessive hormonal secretion in patientswith malignant pheochromocytoma andparaganglioma (Knowledge, Competence,Performance);
• Understand menin function and telomerebiology in pancreatic neuroendocrinetumors (Knowledge);
• Appreciate the clinical trials availablefor patients with parathyroid cancer andenroll them appropriately (Knowledge, Competence, Performance);
• Understand basic, clinical, and translationalgenetics with regard to TP53 germline (Knowledge).

Educational Methods:
• Lecture/Didactic
• Poster Session
• Interactive Groups/Breakouts